Global Endometrial Cancer Market Size, Status and Forecast 2019-2025

SKU ID : QYR-13717272

Publishing Date : 09-Jan-2019

No. of pages : 96

PRICE
3900
7800


  • Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It is the result of the abnormal growth of cells that have the ability to invade or spread to other parts of the body. The first sign is most often vaginal bleeding not associated with a menstrual period. Other symptoms include pain with urination, pain during sexual intercourse, or pelvic pain. Endometrial cancer occurs most commonly after menopause.
    The endometrial cancer market is dominated by North America owing to the rising prevalence of breast cancer.
    Asia-Pacific was projected to be the fastest growing region for the global endometrial cancer market in 2017. The market is expected to witness growth owing to the rising prevalence of diabetes in women, changing lifestyle, and growing obesity within the female population.
    In 2018, the global Endometrial Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

    This report focuses on the global Endometrial Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Endometrial Cancer development in United States, Europe and China.

    The key players covered in this study
    Pfizer
    Johnson & Johnson
    Boston Scientific
    GE
    Karl Storz
    Koninklijke Philips
    Celgene
    Lupin
    LiNA Medical
    Bayer AG
    Cooper Surgical
    Hologic

    Market segment by Type, the product can be split into
    Hysterectomy Techniques
    Radiation
    Hormone Therapy
    Chemotherapy

    Market segment by Application, split into
    Hospitals
    Clinics
    Gynecology Centers
    Others

    Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Endometrial Cancer status, future forecast, growth opportunity, key market and key players.
    To present the Endometrial Cancer development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

    In this study, the years considered to estimate the market size of Endometrial Cancer are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
    For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.